5BXN

Target information

RCSB PDB
5BXN
Title
Yeast 20S proteasome beta2-G170A mutant in complex with Bortezomib
Method
X-RAY DIFFRACTION
Resolution
2.8
Classification
HYDROLASE/HYDROLASE INHIBITOR
Organism
Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
Protein
Proteasome subunit beta type-2 (P25043)
Year
2018
Publication Title
Defective immuno- and thymoproteasome assembly causes severe immunodeficiency.
Abstract

By N-ethyl-N-nitrosourea (ENU) mutagenesis, we generated the mutant mouse line TUB6 that is characterised by severe combined immunodeficiency (SCID) and systemic sterile autoinflammation in homozygotes, and a selective T cell defect in heterozygotes. The causative missense point mutation results in the single amino acid exchange G170W in multicatalytic endopeptidase complex subunit-1 (MECL-1), the β2i-subunit of the immuno- and thymoproteasome. Yeast mutagenesis and crystallographic data suggest that the severe TUB6-phenotype compared to the MECL-1 knockout mouse is caused by structural changes in the C-terminal appendage of β2i that prevent the biogenesis of immuno- and thymoproteasomes. Proteasomes are essential for cell survival, and defective proteasome assembly causes selective death of cells expressing the mutant MECL-1, leading to the severe immunological phenotype. In contrast to the immunosubunits β1i (LMP2) and β5i (LMP7), mutations in the gene encoding MECL-1 have not yet been assigned to human disorders. The TUB6 mutant mouse line exemplifies the involvement of MECL-1 in immunopathogenesis and provides the first mouse model for primary immuno- and thymoproteasome-associated immunodeficiency that may also be relevant in humans.

External Link
RCSB PDB





Ligand information

HET
BO2
Chain ID
H
HET Number
301
Molecular Formula
C19H25BN4O4
Structure
2D structure
IUPAC Name
[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
InChI
InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1
InChI Key
GXJABQQUPOEUTA-RDJZCZTQSA-N
Canonical SMILES
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O
Bioactivity data
CI006008

Covalent Binding

Warhead
Boronic Acid
Reaction Mechanism
Boronic Acid Addition
Residue
THR : 1
Residue Chain
H
Interactions
Pharmacophore Model